Get the Stockscreener App
46.68
1.52%
0.70
Pre-market:
46.69
0.010
+0.02%
Monster Beverage Corp stock is traded at $46.68, with a volume of 9.86M.
It is up +1.52% in the last 24 hours and down -51.91% over the past month.
Monster Beverage is a leader in the energy drink category within the nonalcoholic ready-to-drink beverage market, generating two-thirds of revenue in the US and Canada. The well-known Monster trademark includes brands such as Monster Energy, Monster Ultra, Java Monster, and Juice Monster. The firm also owns other energy drink brands, such as Reign, NOS, Burn, Bang, and Mother, and brews and distributes beers and flavored malt beverages following the acquisition of a craft brewer in 2022. Monster controls branding and innovation but outsources beverage manufacturing and packaging to co-packers and finished goods distribution to bottlers in the global Coca-Cola system (pursuant to a 20-year agreement inked in 2015). Coke is the largest shareholder of Monster, owning a 20% stake.
See More
Previous Close:
$45.98
Open:
$46.44
24h Volume:
9.86M
Relative Volume:
1.67
Market Cap:
$91.45B
Revenue:
$8.79B
Net Income/Loss:
$2.03B
P/E Ratio:
22.65
EPS:
2.0606
Net Cash Flow:
$2.05B
1W Performance:
-50.42%
1M Performance:
-51.91%
6M Performance:
-42.71%
1Y Performance:
-27.23%
1-Day Range:
$46.05
$46.97
1-Week Range:
$45.05
$93.90
52-Week Range:
$45.05
$100.34
Monster Beverage Corp Stock (MNST) Company Profile
Name
Monster Beverage Corp
Sector
Industry
Phone
909-739-6200
Address
1 MONSTER WAY, CORONA, CA
Compare MNST vs KO, PEP, KOF, COKE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MNST
Monster Beverage Corp
|
46.68 | 90.08B | 8.79B | 2.03B | 2.05B | 2.0606 |
KO
Coca Cola Co
|
87.42 | 373.07B | 49.82B | 13.77B | 12.56B | 3.1761 |
PEP
Pepsico Inc
|
140.62 | 189.31B | 96.91B | 10.52B | 9.28B | 7.6247 |
KOF
Coca Cola Femsa Sab De Cv Adr
|
108.84 | 23.08B | 15.88B | 1.31B | 727.67M | 5.9296 |
COKE
Coca Cola Consolidated Inc
|
190.16 | 12.57B | 7.49B | 578.53M | 665.12M | 6.8502 |
Monster Beverage Corp Stock (MNST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-23-26 | Reiterated | Stifel | Buy |
| Apr-20-26 | Reiterated | TD Cowen | Hold |
| Apr-10-26 | Reiterated | BofA Securities | Buy |
| Apr-08-26 | Reiterated | Wells Fargo | Overweight |
| Apr-07-26 | Reiterated | UBS | Neutral |
| Mar-16-26 | Reiterated | Wells Fargo | Overweight |
| Mar-03-26 | Reiterated | Argus | Buy |
| Feb-27-26 | Reiterated | Citigroup | Buy |
| Feb-27-26 | Reiterated | Deutsche Bank | Buy |
| Feb-27-26 | Reiterated | Evercore ISI | Outperform |
| Feb-27-26 | Reiterated | JP Morgan | Neutral |
| Feb-27-26 | Reiterated | Jefferies | Buy |
| Feb-27-26 | Reiterated | Piper Sandler | Overweight |
| Feb-27-26 | Reiterated | Stifel | Buy |
| Feb-27-26 | Reiterated | TD Cowen | Hold |
| Feb-27-26 | Reiterated | UBS | Neutral |
| Feb-27-26 | Reiterated | Wells Fargo | Overweight |
| Feb-24-26 | Reiterated | RBC Capital Mkts | Outperform |
| Feb-23-26 | Reiterated | Evercore ISI | Outperform |
| Feb-20-26 | Reiterated | Deutsche Bank | Buy |
| Jan-27-26 | Reiterated | Argus | Buy |
| Jan-26-26 | Reiterated | Morgan Stanley | Overweight |
| Jan-16-26 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Jan-14-26 | Reiterated | Citigroup | Buy |
| Jan-14-26 | Reiterated | UBS | Neutral |
| Jan-08-26 | Reiterated | TD Cowen | Hold |
| Jan-05-26 | Reiterated | Wells Fargo | Overweight |
| Dec-19-25 | Reiterated | BofA Securities | Buy |
| Dec-03-25 | Reiterated | BMO Capital Markets | Market Perform |
| Dec-03-25 | Reiterated | Goldman | Buy |
| Dec-03-25 | Reiterated | Piper Sandler | Overweight |
| Dec-03-25 | Reiterated | Wells Fargo | Overweight |
| Dec-01-25 | Reiterated | Piper Sandler | Overweight |
| Dec-01-25 | Reiterated | RBC Capital Mkts | Outperform |
| Nov-07-25 | Reiterated | BofA Securities | Buy |
| Nov-07-25 | Reiterated | Deutsche Bank | Buy |
| Nov-07-25 | Reiterated | Evercore ISI | Outperform |
| Nov-07-25 | Reiterated | Goldman | Buy |
| Nov-07-25 | Reiterated | JP Morgan | Neutral |
| Nov-07-25 | Reiterated | Morgan Stanley | Overweight |
| Nov-07-25 | Reiterated | Piper Sandler | Overweight |
| Nov-07-25 | Reiterated | UBS | Neutral |
| Nov-07-25 | Reiterated | Wells Fargo | Overweight |
| Oct-30-25 | Reiterated | Deutsche Bank | Buy |
| Oct-24-25 | Reiterated | JP Morgan | Neutral |
| Oct-24-25 | Reiterated | Stifel | Buy |
| Oct-10-25 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-08-25 | Reiterated | UBS | Neutral |
| Sep-16-25 | Reiterated | Citigroup | Buy |
| Aug-13-25 | Reiterated | Roth Capital | Neutral |
| Aug-08-25 | Reiterated | JP Morgan | Neutral |
| Aug-08-25 | Reiterated | Morgan Stanley | Overweight |
| Aug-08-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-08-25 | Reiterated | RBC Capital Mkts | Outperform |
| Aug-08-25 | Reiterated | UBS | Neutral |
| Aug-08-25 | Reiterated | Wells Fargo | Overweight |
| Jul-17-25 | Reiterated | UBS | Neutral |
| Jul-09-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Jun-13-25 | Reiterated | Goldman | Buy |
| Jun-13-25 | Reiterated | Wells Fargo | Overweight |
| Jun-12-25 | Reiterated | Morgan Stanley | Overweight |
| Jun-12-25 | Resumed | Stifel | Buy |
| May-14-25 | Reiterated | Roth Capital | Neutral |
| May-09-25 | Reiterated | JP Morgan | Neutral |
| May-09-25 | Reiterated | Morgan Stanley | Overweight |
| May-09-25 | Reiterated | Piper Sandler | Neutral |
| May-09-25 | Reiterated | TD Cowen | Hold |
| May-09-25 | Reiterated | UBS | Neutral |
| May-05-25 | Reiterated | Wells Fargo | Overweight |
| May-02-25 | Reiterated | JP Morgan | Neutral |
| Apr-25-25 | Reiterated | BofA Securities | Buy |
| Apr-23-25 | Reiterated | Truist | Sell |
| Apr-17-25 | Reiterated | UBS | Neutral |
| Apr-16-25 | Reiterated | Jefferies | Buy |
| Apr-14-25 | Reiterated | Citigroup | Buy |
| Apr-02-25 | Reiterated | Wells Fargo | Overweight |
| Mar-03-25 | Reiterated | UBS | Neutral |
| Feb-28-25 | Reiterated | Citigroup | Buy |
| Feb-28-25 | Reiterated | Deutsche Bank | Buy |
| Feb-28-25 | Reiterated | JP Morgan | Neutral |
| Feb-28-25 | Reiterated | Morgan Stanley | Overweight |
| Dec-19-24 | Reiterated | Exane BNP Paribas | Underperform |
| Dec-06-24 | Initiated | Needham | Hold |
| Nov-12-24 | Reiterated | Argus | Buy |
| Nov-11-24 | Reiterated | TD Cowen | Hold |
| Nov-08-24 | Reiterated | Deutsche Bank | Buy |
| Nov-08-24 | Reiterated | JP Morgan | Neutral |
| Nov-08-24 | Reiterated | Stifel | Buy |
| Nov-08-24 | Reiterated | UBS | Neutral |
| Nov-05-24 | Reiterated | Wells Fargo | Overweight |
| Nov-04-24 | Reiterated | JP Morgan | Neutral |
| Oct-15-24 | Reiterated | BofA Securities | Buy |
| Oct-07-24 | Reiterated | UBS | Neutral |
| Aug-12-24 | Reiterated | ROTH MKM | Neutral |
| Aug-09-24 | Reiterated | Truist | Sell |
| Aug-08-24 | Reiterated | Citigroup | Buy |
| Aug-08-24 | Reiterated | Deutsche Bank | Buy |
| Aug-08-24 | Reiterated | JP Morgan | Neutral |
| Aug-08-24 | Reiterated | Jefferies | Buy |
| Aug-08-24 | Reiterated | Piper Sandler | Neutral |
| Aug-08-24 | Reiterated | RBC Capital Mkts | Outperform |
| Aug-08-24 | Reiterated | UBS | Neutral |
| Aug-08-24 | Reiterated | Wells Fargo | Overweight |
| Jul-23-24 | Reiterated | JP Morgan | Neutral |
| Jul-15-24 | Reiterated | TD Cowen | Hold |
| Jul-10-24 | Reiterated | BofA Securities | Buy |
| Jul-10-24 | Reiterated | Citigroup | Buy |
| Jun-25-24 | Reiterated | Wells Fargo | Overweight |
| Jun-24-24 | Initiated | Exane BNP Paribas | Underperform |
| Jun-17-24 | Reiterated | Stifel | Buy |
| May-03-24 | Reiterated | Morgan Stanley | Overweight |
| May-03-24 | Reiterated | Piper Sandler | Neutral |
| May-03-24 | Reiterated | UBS | Neutral |
| Jan-17-24 | Reiterated | BMO Capital Markets | Market Perform |
| Jan-17-24 | Reiterated | Citigroup | Buy |
| Jan-17-24 | Reiterated | Goldman | Buy |
| Jan-17-24 | Reiterated | JP Morgan | Overweight |
| Nov-20-23 | Reiterated | Piper Sandler | Neutral |
| Nov-20-23 | Reiterated | ROTH MKM | Neutral |
| Nov-13-23 | Initiated | Jefferies | Buy |
| Nov-03-23 | Reiterated | Wells Fargo | Overweight |
| Oct-31-23 | Reiterated | JP Morgan | Overweight |
| Oct-24-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-23-23 | Reiterated | Deutsche Bank | Buy |
| Oct-05-23 | Upgrade | CFRA | Hold → Buy |
| Aug-14-23 | Initiated | HSBC Securities | Buy |
| Aug-10-23 | Reiterated | ROTH MKM | Neutral |
| Aug-07-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-04-23 | Reiterated | UBS | Neutral |
| Jul-31-23 | Reiterated | Stifel | Buy |
| Jul-25-23 | Reiterated | Evercore ISI | Outperform |
| Jun-08-23 | Initiated | Piper Sandler | Neutral |
| May-08-23 | Reiterated | BMO Capital Markets | Market Perform |
| May-08-23 | Reiterated | ROTH MKM | Neutral |
| May-05-23 | Reiterated | BofA Securities | Buy |
| May-05-23 | Reiterated | Citigroup | Buy |
| May-05-23 | Reiterated | Deutsche Bank | Buy |
| May-05-23 | Reiterated | Goldman | Buy |
| May-05-23 | Reiterated | JP Morgan | Overweight |
| May-05-23 | Reiterated | Morgan Stanley | Overweight |
| May-05-23 | Reiterated | RBC Capital Mkts | Outperform |
| May-05-23 | Reiterated | Truist | Buy |
| May-05-23 | Reiterated | UBS | Neutral |
| May-05-23 | Reiterated | Wells Fargo | Overweight |
| Apr-06-23 | Reiterated | UBS | Neutral |
| Apr-06-23 | Reiterated | Wedbush | Neutral |
| Mar-06-23 | Upgrade | Redburn | Neutral → Buy |
| Mar-01-23 | Reiterated | BMO Capital Markets | Market Perform |
| Mar-01-23 | Downgrade | CFRA | Buy → Hold |
| Mar-01-23 | Reiterated | Citigroup | Buy |
| Mar-01-23 | Reiterated | JP Morgan | Overweight |
| Mar-01-23 | Reiterated | Morgan Stanley | Overweight |
| Mar-01-23 | Reiterated | Truist | Buy |
| Mar-01-23 | Reiterated | Wells Fargo | Overweight |
| Feb-17-23 | Initiated | Citigroup | Buy |
| Jan-18-23 | Reiterated | BMO Capital Markets | Market Perform |
| Jan-18-23 | Reiterated | Evercore ISI | Outperform |
| Nov-04-22 | Reiterated | BofA Securities | Buy |
| Nov-04-22 | Reiterated | Morgan Stanley | Overweight |
| Nov-04-22 | Reiterated | RBC Capital Mkts | Outperform |
| Nov-04-22 | Reiterated | UBS | Neutral |
| Nov-04-22 | Reiterated | Wells Fargo | Overweight |
| Nov-01-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-11-22 | Initiated | Wedbush | Neutral |
| Aug-05-22 | Reiterated | RBC Capital Mkts | Outperform |
| Jul-05-22 | Initiated | ROTH Capital | Neutral |
| Jun-06-22 | Reiterated | Morgan Stanley | Overweight |
| May-18-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Feb-25-22 | Reiterated | Citigroup | Buy |
| Feb-25-22 | Reiterated | Cowen | Market Perform |
| Feb-25-22 | Reiterated | Deutsche Bank | Buy |
| Feb-25-22 | Reiterated | Guggenheim | Buy |
| Feb-25-22 | Reiterated | JP Morgan | Neutral |
| Feb-17-22 | Initiated | BMO Capital Markets | Market Perform |
| Nov-01-21 | Initiated | Redburn | Neutral |
| Oct-13-21 | Downgrade | Jefferies | Buy → Hold |
| Jul-23-21 | Upgrade | Citigroup | Neutral → Buy |
| May-07-21 | Reiterated | Truist | Buy |
| Feb-26-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-20-21 | Initiated | Bernstein | Mkt Perform |
| Jan-15-21 | Reiterated | Citigroup | Neutral |
| Jan-15-21 | Reiterated | Deutsche Bank | Buy |
| Jan-15-21 | Reiterated | Truist | Buy |
| Dec-10-20 | Reiterated | Morgan Stanley | Overweight |
| Dec-08-20 | Initiated | Wells Fargo | Overweight |
| Nov-17-20 | Upgrade | UBS | Sell → Neutral |
| Nov-03-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-20-20 | Reiterated | Guggenheim | Buy |
| May-28-20 | Reiterated | Stifel | Buy |
| May-11-20 | Downgrade | Citigroup | Buy → Neutral |
| May-05-20 | Reiterated | Guggenheim | Buy |
| Apr-16-20 | Resumed | BofA/Merrill | Buy |
| Apr-01-20 | Resumed | Goldman | Buy |
| Mar-20-20 | Upgrade | Guggenheim | Neutral → Buy |
| Mar-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-03-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-17-19 | Downgrade | Cowen | Outperform → Market Perform |
| Oct-02-19 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-08-19 | Reiterated | BMO Capital Markets | Market Perform |
| Aug-08-19 | Reiterated | Morgan Stanley | Equal-Weight |
| Aug-08-19 | Reiterated | UBS | Sell |
| Apr-01-19 | Downgrade | Macquarie | Outperform → Neutral |
| Mar-28-19 | Reiterated | Morgan Stanley | Equal-Weight |
View All
Monster Beverage Corp Stock (MNST) Latest News
Monster Beverage stock steadies after Q2 earnings beat as margin questions linger - AD HOC NEWS
Monster Beverage (MNST) Stock Looks Near Fair Value While Earnings Price In More - simplywall.st
Monster Beverage Corporation (MNST) Stock Forecasts - Yahoo Finance
Monster Beverage achieves monster results - Food Business News
Rep. Josh Gottheimer Purchases Shares of Monster Beverage Corporation (NASDAQ:MNST) - MarketBeat
Will Strong Q2 2026 International-Driven Results Change Monster Beverage's (MNST) Margin and Growth Narrative? - Yahoo Finance
Monster Beverage Stock Split: Why MNST Shares Double, Not Value on August 11 - EBC Financial Group
Is iShares US Consumer Staples ETF a Better Buy Than Invesco Food & Beverage? - The Motley Fool
Fund Update: 153,098 MONSTER BEVERAGE (MNST) shares added to Vanguard Personalized Indexing Management, LLC portfolio - quiverquant.com
Monster Beverage Corp Stock (MNST) Moved Down by 49.76% on Aug 11: Key Drivers Unveiled - TradingKey
Why is Monster Beverage stock climbing today? By Investing.com - Investing.com UK
MNST Q2 Deep Dive: International Acceleration, Margin Compression, and Innovation Drive Focus - Yahoo Finance
Monster Beverage Rallies on Split, Earnings, Upgrades - TradingPedia
Why is Monster Beverage stock climbing today? - Investing.com
MNST Looks 16.0% Overvalued on GF Value™ as Market Reacts to Q2 EPS - GuruFocus
Monster Beverage stock hits 52-week low at $45.72 By Investing.com - Investing.com UK
Monster Beverage stock hits 52-week low at $45.72 - Investing.com
Why Monster Beverage (MNST) Is Back In The Spotlight - simplywall.st
Monster Beverage Corp. stock outperforms competitors on strong trading day - MarketWatch
Is Monster Beverage’s Best-Case Scenario Already Priced Into the Stock? - MarketBeat
Investing in Monster Beverage (MNST)? Don't Miss Assessing Its International Revenue Trends - Yahoo Finance
Monster Beverage (NASDAQ:MNST) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat
stock market monster |fundamental engine + market mechanism| for OANDA:XAUUSD by currencynerd - TradingView
MNST Maintained by RBC Capital -- Price Target Raised to $100 - GuruFocus
Monster Beverage Corp (MNST) Shares Fall 4.0% -- GF Value Says S - GuruFocus
Monster Beverage Corp. stock underperforms Friday when compared to competitors - MarketWatch
MNST Maintained by Piper Sandler -- Price Target Raised to $101 - GuruFocus
Monster Beverage (NASDAQ:MNST) Price Target Raised to $101.00 - MarketBeat
Monster Beverage Beats Q2 Earnings on Broad-Based Sales Growth - Yahoo Finance
MNST Maintained by Evercore ISI Group -- Price Target Raised to $105 - GuruFocus
Monster Beverage (NASDAQ:MNST) Stock Price Expected to Rise, UBS Group Analyst Says - MarketBeat
Evercore Issues Positive Forecast for Monster Beverage (NASDAQ:MNST) Stock Price - MarketBeat
Monster Beverage Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
Monster Beverage Corp 2026: Revenue $2.54B, EPS $0.59— 10-Q Summary - TradingView
Monster Beverage Corporation (NASDAQ:MNST) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
MNST Price History for Monster Beverage Corp Stock - Barchart.com
Monster Beverage Corp (MNST) (Q2 2026) Earnings Call Highlights: Record Sales and Global ... By GuruFocus - Investing.com Canada
Monster Beverage Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: Monster Beverage tops Q2 2026 forecasts as sales hit record - Investing.com
Monster Beverage Sees Sales Jump on International Growth - Bloomberg.com
Is Monster Beverage Corp (MNST) Overvalued After Q2 Earnings Bea - GuruFocus
MONSTER BEVERAGE ($MNST) Releases Q2 2026 Earnings - Quiver Quantitative
Monster Beverage Sales Rise on International Growth - WSJ
Monster Beverage Corp (MNST) Q2 2026 Earnings - 24/7 Wall St.
MONSTER BEVERAGE CORP : RBC RAISES TARGET PRICE TO $100 FROM $97 - Bitget
Monster Beverage: Q2 Earnings Snapshot - Barchart.com
Monster Beverage earnings in focus as growth faces valuation test By Investing.com - Investing.com Canada
Monster Beverage Reports 2026 Second Quarter Financial Results - marketscreener.com
Monster Beverage earnings in focus as growth faces valuation test - Investing.com
MONSTER BEVERAGE CORP : PIPER SANDLER RAISES TARGET PRICE TO $101 FROM $94 - Bitget
Monster Beverage (NASDAQ:MNST) Shares Bought Rep. Jared Moskowitz - marketbeat.com
Monster Beverage Corp Stock (MNST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):